district of delaware in re : chapter 11 insys therapeutics

151
RLF1 21620685v.1 UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE ------------------------------------------------------x : In re : Chapter 11 : INSYS THERAPEUTICS, INC., et al., : Case No. 19-11292 (KG) : Debtors. 1 : Jointly Administered : : Obj. Deadline: October 10, 2019 at 4:00 p.m. (ET) ------------------------------------------------------x FIRST MONTHLY APPLICATION OF RICHARDS, LAYTON & FINGER, P.A. FOR ALLOWANCE OF COMPENSATION FOR SERVICES RENDERED AND FOR REIMBURSEMENT OF EXPENSES AS CO-COUNSEL TO THE DEBTORS FOR THE PERIOD FROM JUNE 10, 2019 THROUGH JUNE 30, 2019 Name of Applicant: Richards, Layton & Finger, P.A. Authorized to Provide Professional Services to: the above-captioned debtors Date of Retention: July 11, 2019 nunc pro tunc to June 10, 2019 Period for which compensation and reimbursement are sought: June 10, 2019 through June 30, 2019 Amount of Compensation sought as actual, reasonable, and necessary: $268,134.00 (80% of $335,167.50) Amount of Expense Reimbursement sought as actual, reasonable, and necessary: $9,142.37 This is a(n): X monthly ___ interim final application Prior Applications Filed: None. 1 The Debtors in these chapter 11 cases, along with the last four digits of each Debtor’s federal tax identification number, as applicable, are: Insys Therapeutics, Inc. (7886); IC Operations, LLC (9659); Insys Development Company, Inc. (3020); Insys Manufacturing, LLC (0789); Insys Pharma, Inc. (9410); IPSC, LLC (6577); and IPT 355, LLC (0155). The Debtors’ mailing address is 410 S. Benson Lane, Chandler, Arizona 85224. Case 19-11292-KG Doc 648 Filed 09/20/19 Page 1 of 19

Upload: others

Post on 28-Apr-2022

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

RLF1 21620685v.1

UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE

------------------------------------------------------x : In re : Chapter 11 : INSYS THERAPEUTICS, INC., et al., : Case No. 19-11292 (KG) : Debtors.1 : Jointly Administered : : Obj. Deadline: October 10, 2019 at 4:00 p.m. (ET) ------------------------------------------------------x

FIRST MONTHLY APPLICATION OF RICHARDS, LAYTON & FINGER, P.A. FOR ALLOWANCE OF COMPENSATION FOR SERVICES RENDERED AND FOR

REIMBURSEMENT OF EXPENSES AS CO-COUNSEL TO THE DEBTORS FOR THE PERIOD FROM JUNE 10, 2019 THROUGH JUNE 30, 2019

Name of Applicant: Richards, Layton & Finger, P.A. Authorized to Provide Professional Services to: the above-captioned debtors Date of Retention: July 11, 2019 nunc pro tunc to June 10, 2019 Period for which compensation and reimbursement are sought: June 10, 2019 through June 30, 2019 Amount of Compensation sought as actual, reasonable, and necessary: $268,134.00 (80% of $335,167.50) Amount of Expense Reimbursement sought as actual, reasonable, and necessary: $9,142.37 This is a(n): X monthly ___ interim final application Prior Applications Filed: None.

1 The Debtors in these chapter 11 cases, along with the last four digits of each Debtor’s federal tax identification number, as applicable, are: Insys Therapeutics, Inc. (7886); IC Operations, LLC (9659); Insys Development Company, Inc. (3020); Insys Manufacturing, LLC (0789); Insys Pharma, Inc. (9410); IPSC, LLC (6577); and IPT 355, LLC (0155). The Debtors’ mailing address is 410 S. Benson Lane, Chandler, Arizona 85224.

Case 19-11292-KG Doc 648 Filed 09/20/19 Page 1 of 19

Page 2: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

2 RLF1 21620685v.1

COMPENSATION BY PROFESSIONAL JUNE 10, 2019 THROUGH JUNE 30, 2019

Name of Professional Individual

Position, year assumed position, prior relevant

experience, year of obtaining relevant license to practice

Hourly Billing Rate (including changes)

Total Hours Billed

Total Compensation

Mark D. Collins Joined firm as associate in 1993. Director in 1998. Member of DE Bar since 1991.

$975 15.1 $14,722.50

John H. Knight Joined firm as associate in 1998. Director in 2003. Member of MD Bar since 1994. Member of NJ Bar since 1996. Member of DE Bar since 1999.

$900 23.0 $20,700.00

Rudolf Koch Corporate Department. Joined firm as associate in 2006. Director in 2012. Member of DE Bar since 2007. Member of NY Bar since 2004.

$825 2.0 $1,650.00

Paul N. Heath Joined firm as associate in 1999. Director in 2007. Member of DE Bar since 1998.

$800 38.6 $30,880.00

Marcos A. Ramos Joined firm as associate in 2002. Director in 2010. Member of NY Bar since 1995. Member of CA Bar since 1998. Member of MD Bar since 2001. Member of DE Bar since 2003.

$760 77.4 $58,824.00

Amanda R. Steele Joined firm as associate in 2010. Director in 2018. Member of DE Bar since 2010.

$700 80.9 $56,630.00

Case 19-11292-KG Doc 648 Filed 09/20/19 Page 2 of 19

Page 3: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

3 RLF1 21620685v.1

Name of Professional Individual

Position, year assumed position, prior relevant

experience, year of obtaining relevant license to practice

Hourly Billing Rate (including changes)

Total Hours Billed

Total Compensation

Zachary I. Shapiro Joined firm as associate in 2007. Counsel in 2016. Director in 2019. Member of DE Bar since 2008.

$635 22.1 $14,033.50

Robert C. Maddox Joined firm as associate in 2009. Member of DE Bar since 2009.

$625 17.0 $10,625.00

Nathaniel J. Stuhlmiller Corporate Department. Joined firm as associate in 2009. Director in 2019. Member of DE Bar since 2010.

$625 1.0 $625.00

Sarah A. Clark Corporate Department. Joined firm as associate in 2013. Member of DE Bar since 2013.

$560 4.2 $2,352.00

Christopher M. De Lillo Joined firm as associate in 2016. Member of DE Bar since 2017.

$470 137.7 $64,719.00

Megan E. Kenney Joined firm as associate in 2017. Member of DE Bar since 2017.

$420 75.5 $31,710.00

Travis J. Cuomo Joined firm as associate in 2017. Member of DE Bar since 2018.

$420 0.1 $42.00

Cassandra Thompson Summer Associate $275 11.9 $3,272.50

Sheilah A. Jennings Summer Associate $275 7.0 $1,925.00

Carlos B. Terreforte MIS Litigation Support. Joined firm in 2015.

$275 0.3 $82.50

Ann Jerominski Paralegal since 1995. Joined firm in 2000.

$265 4.8 $1,272.00

Barbara J. Witters Paralegal since 2000. Joined firm in 2000.

$265 4.9 $1,298.50

Case 19-11292-KG Doc 648 Filed 09/20/19 Page 3 of 19

Page 4: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

4 RLF1 21620685v.1

Name of Professional Individual

Position, year assumed position, prior relevant

experience, year of obtaining relevant license to practice

Hourly Billing Rate (including changes)

Total Hours Billed

Total Compensation

Rebecca V. Speaker Paralegal since 2002. Joined firm in 2001.

$265 16.5 $4,372.50

M. Lynzy McGee Paralegal since 2007. Joined firm in 2016.

$265 56.7 $15,025.50

Tesia S. Smith Case Management Assistant since 2016. Joined firm in 1996.

$140 2.9 $406.00

TOTAL 599.6 $335,167.50

Grand Total $335,167.50 Attorney Compensation $312,710.50 Total Attorney Hours 513.5 Blended Rate $608.98

Case 19-11292-KG Doc 648 Filed 09/20/19 Page 4 of 19

Page 5: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

5 RLF1 21620685v.1

COMPENSATION BY PROJECT CATEGORY JUNE 10, 2019 THROUGH JUNE 30, 2019

Project Category Total Hours Total Fees

Case Administration (A) 24.2 $11,418.00

Creditor Inquiries (B) 1.6 $1,189.50

Meetings (C) 9.4 $5,552.50

Executory Contracts/Unexpired Leases (D) 4.4 $2,065.00

Automatic Stay/Adequate Protection (E) 10.2 $5,511.00

Plan of Re-Organization/Disclosure Statement (F) 1.1 $586.00

Use, Sale, Lease of Assets (G) 12.3 $6,416.50

Cash Collateral/DIP Financing (H) 1.7 $671.00

Claims Administration (I) 36.4 $19,327.50

Court Hearings (J) 103.5 $58,626.00

General Corporate/Real Estate (K) 6.0 $3,211.00

Schedules/SOFA/U.S. Trustee Reports (L) 32.1 $20,595.00

Employee Issues (M) 1.2 $364.50

Environmental (N) 0.0 $0.00

Tax Issues (O) 1.7 $512.50

Litigation/Adversary Proceedings (P) 217.0 $128,654.00

RL&F Retention (Q-1) 54.0 $27,093.00

Retention of Others (Q-2) 71.5 $37,934.50

RL&F Fee Applications (R-1) 0.0 $0.00

Fee Applications of Others (R-2) 4.0 $2,047.50

Vendor/Supplies (S) 1.2 $364.50

Non-Working Travel (T) 0.0 $0.00

Utilities (U) 1.7 $612.50

Insurance (V) 4.4 $2,415.50

TOTAL 599.6 $335,167.50

Case 19-11292-KG Doc 648 Filed 09/20/19 Page 5 of 19

Page 6: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

6 RLF1 21620685v.1

EXPENSE SUMMARY JUNE 10, 2019 THROUGH JUNE 30, 2019

Expense Category Service Provider (if applicable)

Total Expenses

Facsimile $0.00

Conference Calling $163.95

Long Distance Telephone $19.31

In-House Reproduction (Duplication/Printing)

Duplicating: 2,917 @ $.10 pg. Printing: 11,652 @ $.10 pg.

$1,456.90

Outside Reproduction $0.00

Legal Research $210.75

Filing/Court Fees FILE & SERVEXPRESS; Lexis Nexis; USBC

$81.50

Court Reporting Reliable $969.14

Travel Expenses $0.00

Inside Courier & Expense Carriers

$0.00

Outside Courier & Expense Carriers

Blue Marble $286.94

Postage $3.90

Binding $0.00

Business Meals See attached meal chart $3,203.66

Document Retrieval $203.10

Record Retrieval $0.00

Professional Services $0.00

Overtime See attached overtime chart $359.42

Room Rental DoubleTree Hotel – Formation Meeting

$2,183.80

Equipment Rental $0.00

Stationery Supplies $0.00

TOTAL $9,142.37

Case 19-11292-KG Doc 648 Filed 09/20/19 Page 6 of 19

Page 7: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

7 RLF1 21620685v.1

BUSINESS MEAL DETAIL

Date Provider Meal & Number of

people

Description Amount

6/10/2019 La Fia Lunch for 25 Prepare for first day hearing $619.50 6/10/2019 Iron Hill Dinner for 2 Finalize and file adversary

complaint and related documents; Assist with first day hearing preparations

$62.51

6/11/2019 Manhattan Bagel Breakfast for 25 Prepare for first day hearing $400.00 6/11/2019 La Fia Lunch for 25 Prepare for first day hearing $619.50 6/17/2019 The Farmer & the

Cow Dinner for 1 Finalize and file various

retention applications $28.15

6/17/2019 Phubs Dinner for 1 Finalize retention applications and research re: subordination

$17.17

6/19/2019 Manhattan Bagel Breakfast for 5 Prepare for IDI, formation meeting

$135.00

6/19/2019 La Fia Lunch for 5 Prepare for IDI, formation meeting

$141.00

6/23/2019 The Verandah Lunch for 1 Prepare for depositions $15.00 6/24/2019 Manhattan Bagel Breakfast for 10 Prepare for depositions $174.00 6/24/2019 Rodney Grille Drinks for 10 Prepare for depositions $29.90 6/24/2019 Rodney Grille Snacks for 10 Prepare for depositions $56.39 6/24/2019 Cavanaughs Lunch for 10 Prepare for depositions $159.00 6/24/2019 Iron Hill Dinner for 1 Finalize and file retention

application, OCP motion, interim compensation motion and revised notice of estimation motion

$8.17

6/25/2019 Manhattan Bagel Breakfast for 20 Prepare for depositions $245.00 6/25/2019 La Fia Lunch for 20 Prepare for depositions $482.00 6/27/2019 Chelsea Tavern Dinner for 1 Review 327(e) applications $11.37

TOTAL $3,203.66

SECRETARIAL OVERTIME DETAIL

Date

Secretary Description of Work Performed Total Amount

6/10/19 Carol Borris Assist co-counsel in preparation for first day hearing 6/11/19 Jeanne Carrera Assist co-counsel in preparation for first day hearing TOTAL $359.42

Case 19-11292-KG Doc 648 Filed 09/20/19 Page 7 of 19

Page 8: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

RLF1 21620685v.1

UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE

------------------------------------------------------x : In re : Chapter 11 : INSYS THERAPEUTICS, INC., et al., : Case No. 19-11292 (KG) : Debtors.1 : Jointly Administered : : Obj. Deadline: October 10, 2019 at 4:00 p.m. (ET) ------------------------------------------------------x

FIRST MONTHLY APPLICATION OF RICHARDS, LAYTON & FINGER, P.A. FOR ALLOWANCE OF COMPENSATION FOR SERVICES RENDERED AND FOR

REIMBURSEMENT OF EXPENSES AS CO-COUNSEL TO THE DEBTORS FOR THE PERIOD FROM JUNE 10, 2019 THROUGH JUNE 30, 2019

Pursuant to Sections 330 and 331 of Title 11 of the United States Code, §§ 101-

1532 (the “Bankruptcy Code”), Rule 2016 of the Federal Rules of Bankruptcy Procedure (the

“Bankruptcy Rules”), Rule 2016-2 of the Local Rules of Bankruptcy Practice and Procedure of

the United States Bankruptcy Court for the District of Delaware (the “Local Rules”), the Order

(I) Establishing Procedures for Interim Compensation and Reimbursement of Expenses of

Professionals and (II) Granting Related Relief, dated July 23, 2019 [Docket No. 329] (the

“Interim Compensation Order”), Richards, Layton & Finger, P.A. (“RL&F”) hereby files this

First Monthly Application of Richards, Layton & Finger, P.A. for Allowance of Compensation

for Services Rendered and for Reimbursement of Expenses as Co-Counsel to the Debtors for the

Period from June 10, 2019 through June 30, 2019 (the “Application”). By the Application,

RL&F seeks a monthly allowance pursuant to the Interim Compensation Order with respect to

the sums of $335,167.50 as compensation and $9,142.37 for reimbursement of actual and

1 The Debtors in these chapter 11 cases, along with the last four digits of each Debtor’s federal tax identification number, as applicable, are: Insys Therapeutics, Inc. (7886); IC Operations, LLC (9659); Insys Development Company, Inc. (3020); Insys Manufacturing, LLC (0789); Insys Pharma, Inc. (9410); IPSC, LLC (6577); and IPT 355, LLC (0155). The Debtors’ mailing address is 410 S. Benson Lane, Chandler, Arizona 85224.

Case 19-11292-KG Doc 648 Filed 09/20/19 Page 8 of 19

Page 9: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

2 RLF1 21620685v.1

necessary expenses, for a total of $344,309.87 for the period June 10, 2019 through and

including June 30, 2019 (the “Compensation Period”). In support of this Application, RL&F

respectfully represents as follows:

Background

1. On June 10, 2019 (the “Petition Date”), Insys Therapeutics, Inc. and its affiliated

debtors in the above-captioned chapter 11 cases (collectively, the “Debtors”) filed voluntary

petitions for relief under chapter 11 of the Bankruptcy Code.

2. RL&F was retained effective as of the Petition Date by this Court’s order, dated

July 11, 2019 [Docket No. 274] (the “Retention Order”). The Retention Order authorized

RL&F to be compensated on an hourly basis and to be reimbursed for actual and necessary out-

of-pocket expenses.

Compensation Paid and Its Source

3. All services for which compensation is requested by RL&F were performed for or

on behalf of the Debtors.

4. Except to the extent of the retainer paid to RL&F as described in the application

seeking approval of RL&F’s employment by the Debtors during the period covered by this

Application, RL&F has received no payment and no promises for payment from any source for

services rendered or to be rendered in any capacity whatsoever in connection with the matters

covered by this Application. There is no agreement or understanding between RL&F and any

other person other than the directors of RL&F for the sharing of compensation to be received for

services rendered in these cases.

Case 19-11292-KG Doc 648 Filed 09/20/19 Page 9 of 19

Page 10: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

3 RLF1 21620685v.1

Fee Statements

5. The fee statement for the Compensation Period is attached hereto as Exhibit A.

This statement contains daily time logs describing the time spent by each attorney and

paraprofessional for this period. To the best of RL&F’s knowledge, this Application complies

with Sections 330 and 331 of the Bankruptcy Code, the applicable Bankruptcy Rules, the

Guidelines adopted by the Office of the United States Trustee, Del. Bankr. L.R. 2016-2, and the

Interim Compensation Order.

Actual and Necessary Expenses

6. A summary of actual and necessary expenses and daily logs of expenses incurred

by RL&F during the Compensation Period is attached hereto as Exhibit B. RL&F charges all of

its bankruptcy clients $0.10 per page for photocopying expenses and $0.10 per page for printing

jobs.

7. Regarding providers of on-line legal research (e.g., LEXIS and WESTLAW),

RL&F charges all of its clients the standard usage rates these providers charge, which, due to

contractual flat fees, may not always equal RL&F’s actual cost. RL&F currently is under

contract to pay these providers a flat fee every month. Charging its clients the on-line providers’

standard usage rates allows RL&F to cover adequately the monthly flat fees it must pay to these

types of providers.

8. RL&F believes the foregoing rates are the market rates that the majority of law

firms charge clients for such services. In addition, RL&F believes that such charges are in

accordance with the American Bar Association’s (“ABA”) guidelines, as set forth in the ABA’s

Statement of Principles, dated January 12, 1995, regarding billing for disbursements and other

charges.

Case 19-11292-KG Doc 648 Filed 09/20/19 Page 10 of 19

Page 11: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

4 RLF1 21620685v.1

Summary of Services Rendered

9. The directors and associates of RL&F who have rendered professional services in

these cases are as follows: Mark D. Collins, John H. Knight, Rudolf Koch, Paul N. Heath,

Marcos A. Ramos, Amanda R. Steele, Zachary I. Shapiro, Robert C. Maddox, Nathaniel J.

Stuhlmiller, Sarah A. Clark, Christopher M. De Lillo, Megan E. Kenney, Travis J. Cuomo,

Cassandra Thompson and Sheilah A. Jennings. The paraprofessionals of RL&F who have

provided service to these attorneys in these cases are as follows: Carlos B. Terreforte, Ann

Jerominski, Barbara J. Witters, Rebecca V. Speaker, M. Lynzy McGee and Tesia S. Smith.

10. RL&F, by and through the above-named persons, has prepared and/or assisted in

the preparation of various applications and orders submitted to the United States Bankruptcy

Court for the District of Delaware (the “Court”) for consideration, advised the Debtors on a

regular basis with respect to various matters in connection with these cases, and has performed

all necessary professional services which are described and narrated in detail hereinafter.

Summary of Services By Project

11. The services rendered by RL&F during the Compensation Period can be grouped

into the categories set forth below. These categories are generally described below, with a more

detailed identification of the actual services provided set forth on the attached Exhibit A. The

attorneys and paraprofessionals who rendered services relating to each category are identified,

along with the number of hours for each individual and the total compensation sought for each

category, in Exhibit A attached hereto.

Case 19-11292-KG Doc 648 Filed 09/20/19 Page 11 of 19

Page 12: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

5 RLF1 21620685v.1

A. Case Administration/Miscellaneous Matters

Fees: $11,418.00 Total Hours: 24.2

This category includes all matters related to filing documents with the Court,

service thereof, maintenance of calendars, review of work in process reports, review of notices of

appearance and maintaining service lists.

B. Creditor Inquiries

Fees: $1,189.50 Total Hours: 1.6

This category includes all matters related to responding to creditor inquiries.

C. Meetings

Fees: $5,552.50 Total Hours: 9.4

This category includes all matters related to preparing for and attending meetings

with Debtors, the Official Committee of Unsecured Creditors, individual creditors, the U.S.

Trustee, co-counsel and the Debtors’ other professionals.

D. Executory Contracts/Unexpired Leases

Fees: $2,065.00 Total Hours: 4.4

This category includes all matters related to contract and lease analysis and

matters related to assumption, assignment or rejection of executory contracts and unexpired

leases.

E. Automatic Stay/Adequate Protection

Fees: $5,511.00 Total Hours: 10.2

This category includes all matters related to and including all motions to modify

the automatic stay, issues related to the effect of the automatic stay or pending matters, and all

other types of actions where adequate protection is the central issue.

Case 19-11292-KG Doc 648 Filed 09/20/19 Page 12 of 19

Page 13: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

6 RLF1 21620685v.1

F. Plan of Reorganization/Disclosure Statement

Fees: $586.00 Total Hours: 1.1

This category includes all matters related to review, formulation, negotiation,

preparation and promulgation of plans of reorganization, disclosure statements, and related

corporate documentation and research relating thereto.

G. Use, Sale, Lease of Assets

Fees: $6,416.50 Total Hours: 12.3

This category includes all matters relating to acquisitions, dispositions and other

postpetition uses of property of the estate.

H. Cash Collateral/DIP Financing

Fees: $671.00 Total Hours: 1.7

This category includes all matters relating to negotiation and documentation of

the allocation agreement and related issues.

I. Claims Administration

Fees: $19,327.50 Total Hours: 36.4

This category includes all matters related to and including claims administration

matters and bar date matters, including claims objections and related contested matters.

J. Court Hearings

Fees: $58,626.00 Total Hours: 103.5

This category includes all matters related to preparation for and attendance at

court hearings.

Case 19-11292-KG Doc 648 Filed 09/20/19 Page 13 of 19

Page 14: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

7 RLF1 21620685v.1

K. General Corporate/Real Estate

Fees: $3,211.00 Total Hours: 6.0

This category includes all matters relating to transactional, corporate governance

and related matters involving the Debtors’ business operations that are not part of a plan of

reorganization or disclosure statement.

L. Schedules/SOFA/U.S. Trustee Reports & Inquiries

Fees: $20,595.00 Total Hours: 32.1

This category includes responding to inquiries from the U.S. Trustee regarding

retention applications and other pleadings filed and preparation of schedules and amendments,

statements of financial affairs and amendments, operating reports and other reports required by

the U.S. Trustee or the Bankruptcy Court.

M. Employee Issues

Fees: $364.50 Total Hours: 1.2

This category includes all matters related to employee wages, benefits, collective

bargaining issues, other employee relations matters, ERISA, and retirement benefits.

N. Environmental

Fees: $0.00 Total Hours: 0.0

This category includes all environmental matters, other than environmental

aspects of the plan of reorganization.

O. Tax Issues

Fees: $512.50 Total Hours: 1.7

This category includes all federal and state income, property, employment, excise

and other tax matters, other than the tax aspects of the plan of reorganization.

Case 19-11292-KG Doc 648 Filed 09/20/19 Page 14 of 19

Page 15: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

8 RLF1 21620685v.1

P. Litigation/Adversary Proceedings

Fees: $128,654.00 Total Hours: 217.0

This category includes all matters related to litigation and adversary proceedings.

Q-1. RL&F Applications

Fees: $27,093.00 Total Hours: 54.0

This category includes all matters related to preparing applications to retain

RL&F and supplements thereto.

Q-2. Retention of Others

Fees: $37,934.50 Total Hours: 71.5

This category includes time spent reviewing applications for retention of other

professionals, objecting to the retention of other professionals and assisting other professionals

with preparing and filing retention applications.

R-1. RL&F Fee Applications

Fees: $0.00 Total Hours: 0.0

This category includes all time spent preparing, reviewing, filing and circulating

monthly invoices and fee applications for RL&F.

R-2. Fee Applications of Others

Fees: $2,047.50 Total Hours: 4.0

This category includes time spent reviewing invoices or applications of other

professionals, objecting to fees of other professionals and assisting other professionals with filing

and circulating monthly invoices and applications.

Case 19-11292-KG Doc 648 Filed 09/20/19 Page 15 of 19

Page 16: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

9 RLF1 21620685v.1

S. Vendor/Suppliers

Fees: $364.50 Total Hours: 1.2

This category includes all matters related to vendors and suppliers, including

reclamation issues.

T. Non-Working Travel

Fees: $0.00 Total Hours: 0.0

This category includes all travel time not otherwise chargeable.

U. Utilities

Fees: $612.50 Total Hours: 1.7

This category includes all matters related to utility issues.

V. Insurance

Fees: $2,415.50 Total Hours: 4.4

This category includes all matters related to insurance policies or coverage.

Valuation of Services

12. Attorneys and paraprofessionals of RL&F have expended a total of 599.6 hours in

connection with this matter during the Compensation Period, as follows:

ATTORNEYS HOURS HOURLY RATE

Mark D. Collins 15.1 $975 John H. Knight 23.0 $900 Rudolf Koch 2.0 $825 Paul N. Heath 38.6 $800 Marcos A. Ramos 77.4 $760 Amanda R. Steele 80.9 $700 Zachary I. Shapiro 22.1 $635 Robert C. Maddox 17.0 $625 Nathaniel J. Stuhlmiller 1.0 $625 Sarah A. Clark 4.2 $560 Christopher M. De Lillo 137.7 $470 Megan E. Kenney 75.5 $420

Case 19-11292-KG Doc 648 Filed 09/20/19 Page 16 of 19

Page 17: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

10 RLF1 21620685v.1

Travis J. Cuomo 0.1 $420 Cassandra Thompson 11.9 $275 Sheilah A. Jennings 7.0 $275

PARAPROFESSIONALS HOURS HOURLY RATE

Ann Jerominski 4.8 $265 Barbara J. Witters 4.9 $265 Rebecca V. Speaker 16.5 $265 M. Lynzy McGee 56.7 $265 Carlos B. Terreforte 0.3 $275 Tesia S. Smith 2.9 $140

The nature of the work performed by these persons is fully set forth in Exhibit A attached

hereto. These are RL&F’s normal hourly rates for work of this character. The reasonable value

of the services rendered by RL&F to the Debtors during the Compensation Period is

$335,167.50.

13. In accordance with the factors enumerated in Section 330 of the Bankruptcy

Code, it is respectfully submitted that the amount requested by RL&F is fair and reasonable

given (a) the complexity of these cases, (b) the time expended, (c) the nature and extent of the

services rendered, (d) the value of such services, and (e) the costs of comparable services other

than in a case under this title. Moreover, RL&F has reviewed the requirements of Del. Bankr.

L.R. 2016-2 and believes that this Application complies with that Rule.

Case 19-11292-KG Doc 648 Filed 09/20/19 Page 17 of 19

Page 18: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

11 RLF1 21620685v.1

WHEREFORE, RL&F respectfully requests that the Court authorize that for the

Compensation Period, an allowance be made to RL&F pursuant to the terms of the Interim

Compensation Order, with respect to the sum of $335,167.50 as compensation for necessary

professional services rendered (80% of which equals $268,134.00), and the sum of $9,142.37 as

100% reimbursement of actual necessary costs and expenses, for a total of $344,309.87 and that

such sums be authorized for payment and for such other and further relief as this Court may

deem just and proper.

Dated: September 20, 2019 Wilmington, Delaware /s/ Zachary I. Shapiro

John H. Knight (No. 3848) Paul N. Heath (No. 3704) Zachary I. Shapiro (No. 5103) RICHARDS, LAYTON & FINGER, P.A. One Rodney Square 920 North King Street Wilmington, Delaware 19801 Telephone: (302) 651-7700 Fax: (302) 651-7701 Email: [email protected] [email protected] [email protected] Attorneys for the Debtors and Debtors in Possession

Case 19-11292-KG Doc 648 Filed 09/20/19 Page 18 of 19

Page 19: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

RLF1 21620685v.1

CERTIFICATION OF COMPLIANCE WITH DEL. BANKR. L.R. 2016-2

I, Zachary I. Shapiro, on this 20th day of September, 2019, certify as follows:

a) I am a director with the applicant firm, Richards, Layton & Finger, P.A.

(“RL&F”), and have been admitted to appear before this Court.

b) I have personally performed many of the legal services rendered by

RL&F, as co-counsel to the Debtors, and am thoroughly familiar with the other work performed

on behalf of the Debtors by the lawyers and other professionals of RL&F.

c) I have reviewed the foregoing Application, and the facts set forth therein

are true and correct to the best of my knowledge, information and belief. Moreover, I have

reviewed Del. Bankr. L.R. 2016-2, and submit that the Application substantially complies with

such rule.

/s/ Zachary I. Shapiro Zachary I. Shapiro (No. 5103)

Case 19-11292-KG Doc 648 Filed 09/20/19 Page 19 of 19

Page 20: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

RLF1 21794390v.1

UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE

------------------------------------------------------x : In re : Chapter 11 : INSYS THERAPEUTICS, INC., et al., : Case No. 19-11292 (KG) : Debtors.1 : Jointly Administered : : Obj. Deadline: October 10, 2019 at 4:00 p.m. (ET) ------------------------------------------------------x

NOTICE OF FEE APPLICATION

PLEASE TAKE NOTICE that Richards, Layton & Finger, P.A. (the

“Applicant”) has today filed the attached First Monthly Application of Richards, Layton &

Finger, P.A. for Allowance of Compensation for Services Rendered and for Reimbursement of

Expenses as Co-Counsel to the Debtors for the Period from June 10, 2019 through June 30,

2019 (the “Application”) with the United States Bankruptcy Court for the District of Delaware

(the “Court”).

PLEASE TAKE FURTHER NOTICE that objections, if any, to the Application

must be made in accordance with the Order (I) Establishing Procedures for Interim

Compensation and Reimbursement of Expenses of Professionals and (II) Granting Related

Relief, dated July 23, 2019 [D.I. 392] (the “Interim Compensation Order”), and must be filed

no later than 4:00 p.m. (Eastern Time) on October 10, 2019 (the “Objection Deadline”) with

the Clerk of the Court, 824 North Market Street, Wilmington, Delaware 19801, and be served

upon: (i) the Debtors c/o Insys Therapeutics, Inc., 410 South Benson Lane, Chandler, Arizona

1 The Debtors in these chapter 11 cases, along with the last four digits of each Debtor’s federal tax identification number, as applicable, are: Insys Therapeutics, Inc. (7886); IC Operations, LLC (9659); Insys Development Company, Inc. (3020); Insys Manufacturing, LLC (0789); Insys Pharma, Inc. (9410); IPSC, LLC (6577); and IPT 355, LLC (0155). The Debtors’ mailing address is 410 S. Benson Lane, Chandler, Arizona 85224.

Case 19-11292-KG Doc 648-1 Filed 09/20/19 Page 1 of 3

Page 21: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

2 RLF1 21794390v.1

85224 (Attn: General Counsel); (ii) attorneys for the Debtors, Weil, Gotshal & Manges LLP, 767

Fifth Avenue, New York, New York 10153 (Attn: Ronit J. Berkovich, Esq. and Candace M.

Arthur, Esq.), and Richard, Layton & Finger, P.A., One Rodney Square, 920 North King Street,

Wilmington, Delaware 19801 (Attn: Paul N. Heath, Esq. and Zachary I. Shapiro, Esq.); (iii) the

Office of the United States Trustee for the District of Delaware, 844 King Street, Suite 2207,

Lockbox 35, Wilmington, Delaware 19801 (Attn: Jane M. Leamy, Esq.); and (iv) the attorneys

for the Committee, Akin Gump Strauss Hauer & Feld LLP, One Bryant Park, New York, New

York 10036 (Attn: Daniel H. Golden, Esq., Mitchell P. Hurley, Esq., and Arik Preis, Esq.) and

Bayard, P.A., 600 N. King Street, Suite 400, Wilmington, Delaware 19801 (Attn: Justin R.

Alberto, Esq. and Erin R. Fay, Esq.).

PLEASE TAKE FURTHER NOTICE that if any responses or objections to the

Application are timely filed in accordance with this notice and the Interim Compensation Order,

a hearing on the Application will be held at the convenience of the Court. Only those objections

made in writing and timely filed in accordance with the Interim Compensation Order and the

procedures described herein will be considered by the Court at such hearing.

PLEASE TAKE FURTHER NOTICE that, pursuant to the Interim Compensation

Order, if no objection to the Application is timely filed by the Objection Deadline, the Applicant

may be paid an amount equal to the lesser of (i) 80 percent of the fees and 100 percent of

expenses requested in the Application or (ii) 80 percent of the fees and 100 percent of the

expenses not subject to an objection without the need for further order of the Court.

Case 19-11292-KG Doc 648-1 Filed 09/20/19 Page 2 of 3

Page 22: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

3 RLF1 21794390v.1

Dated: September 20, 2019 Wilmington, Delaware

/s/ Zachary I. Shapiro RICHARDS, LAYTON & FINGER, P.A. John H. Knight (No. 3848) Paul N. Heath (No. 3704) Zachary I. Shapiro (No. 5103) Christopher M. De Lillo (No. 6355) One Rodney Square 920 N. King Street Wilmington, Delaware 19801 Telephone: (302) 651-7700 Facsimile: (302) 651-7701 -and- WEIL, GOTSHAL & MANGES LLP Gary T. Holtzer (admitted pro hac vice) Ronit J. Berkovich (admitted pro hac vice) Candace M. Arthur (admitted pro hac vice) Olga F. Peshko (admitted pro hac vice) 767 Fifth Avenue New York, New York 10153 Telephone: (212) 310-8000 Facsimile: (212) 310-8007

Attorneys for the Debtors and Debtors in Possession

Case 19-11292-KG Doc 648-1 Filed 09/20/19 Page 3 of 3

Page 23: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

RLF1 21620685v.1

Exhibit A

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 1 of 82

Page 24: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 2 of 82

Page 25: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 3 of 82

Page 26: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 4 of 82

Page 27: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 5 of 82

Page 28: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 6 of 82

Page 29: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 7 of 82

Page 30: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 8 of 82

Page 31: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 9 of 82

Page 32: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 10 of 82

Page 33: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 11 of 82

Page 34: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 12 of 82

Page 35: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 13 of 82

Page 36: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 14 of 82

Page 37: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 15 of 82

Page 38: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 16 of 82

Page 39: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 17 of 82

Page 40: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 18 of 82

Page 41: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 19 of 82

Page 42: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 20 of 82

Page 43: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 21 of 82

Page 44: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 22 of 82

Page 45: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 23 of 82

Page 46: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 24 of 82

Page 47: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 25 of 82

Page 48: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 26 of 82

Page 49: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 27 of 82

Page 50: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 28 of 82

Page 51: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 29 of 82

Page 52: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 30 of 82

Page 53: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 31 of 82

Page 54: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 32 of 82

Page 55: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 33 of 82

Page 56: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 34 of 82

Page 57: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 35 of 82

Page 58: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 36 of 82

Page 59: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 37 of 82

Page 60: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 38 of 82

Page 61: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 39 of 82

Page 62: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 40 of 82

Page 63: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 41 of 82

Page 64: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 42 of 82

Page 65: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 43 of 82

Page 66: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 44 of 82

Page 67: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 45 of 82

Page 68: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 46 of 82

Page 69: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 47 of 82

Page 70: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 48 of 82

Page 71: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 49 of 82

Page 72: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 50 of 82

Page 73: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 51 of 82

Page 74: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 52 of 82

Page 75: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 53 of 82

Page 76: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 54 of 82

Page 77: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 55 of 82

Page 78: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 56 of 82

Page 79: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 57 of 82

Page 80: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 58 of 82

Page 81: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 59 of 82

Page 82: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 60 of 82

Page 83: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 61 of 82

Page 84: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 62 of 82

Page 85: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 63 of 82

Page 86: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 64 of 82

Page 87: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 65 of 82

Page 88: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 66 of 82

Page 89: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 67 of 82

Page 90: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 68 of 82

Page 91: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 69 of 82

Page 92: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 70 of 82

Page 93: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 71 of 82

Page 94: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 72 of 82

Page 95: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 73 of 82

Page 96: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 74 of 82

Page 97: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 75 of 82

Page 98: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 76 of 82

Page 99: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 77 of 82

Page 100: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 78 of 82

Page 101: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 79 of 82

Page 102: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 80 of 82

Page 103: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 81 of 82

Page 104: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-2 Filed 09/20/19 Page 82 of 82

Page 105: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

RLF1 21620685v.1

Exhibit B

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 1 of 47

Page 106: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 2 of 47

Page 107: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 3 of 47

Page 108: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 4 of 47

Page 109: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 5 of 47

Page 110: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 6 of 47

Page 111: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 7 of 47

Page 112: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 8 of 47

Page 113: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 9 of 47

Page 114: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 10 of 47

Page 115: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 11 of 47

Page 116: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 12 of 47

Page 117: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 13 of 47

Page 118: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 14 of 47

Page 119: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 15 of 47

Page 120: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 16 of 47

Page 121: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 17 of 47

Page 122: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 18 of 47

Page 123: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 19 of 47

Page 124: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 20 of 47

Page 125: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 21 of 47

Page 126: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 22 of 47

Page 127: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 23 of 47

Page 128: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 24 of 47

Page 129: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 25 of 47

Page 130: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 26 of 47

Page 131: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 27 of 47

Page 132: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 28 of 47

Page 133: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 29 of 47

Page 134: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 30 of 47

Page 135: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 31 of 47

Page 136: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 32 of 47

Page 137: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 33 of 47

Page 138: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 34 of 47

Page 139: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 35 of 47

Page 140: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 36 of 47

Page 141: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 37 of 47

Page 142: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 38 of 47

Page 143: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 39 of 47

Page 144: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 40 of 47

Page 145: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 41 of 47

Page 146: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 42 of 47

Page 147: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 43 of 47

Page 148: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 44 of 47

Page 149: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 45 of 47

Page 150: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 46 of 47

Page 151: DISTRICT OF DELAWARE In re : Chapter 11 INSYS THERAPEUTICS

Case 19-11292-KG Doc 648-3 Filed 09/20/19 Page 47 of 47